Drug intelligence / Profile preview

Benebellum

Development stage
Unknown
Lead developer
Skin Tech Pharma Group
Modality
Small Molecules
Administration
Topical
01

Overview

Benebellum is a cosmeceutical skincare line developed by Skin Tech Pharma Group, specifically formulated to address hyperpigmentation, photoaging, and the damaging effects of blue light exposure. The product range includes topical formulations such as serums, foams, and creams that incorporate active ingredients like tranexamic acid and 4-hexylresorcinol. These molecules work synergistically to inhibit melanin synthesis at multiple stages of the melanogenesis pathway. Indicated for skin rejuvenation and repair, the Benebellum line aims to reduce dark spots, improve skin tone uniformity, and enhance overall radiance while providing protective benefits against environmental stressors. Although it contains biologically active molecules, it is categorized as a cosmeceutical/aesthetic medicine product rather than a traditional pharmaceutical drug.

Brand names
BenebellumTX SolutionTX FoamLumina Night CreamFulgora SPF 50+
02

Targets

PLG (Plasminogen)TYR (Tyrosinase)

Beyond the preview

Go deeper on Benebellum.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Benebellum.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call